Primary Record
Galeterone
- In stock
- 9,063 g
- Purity
- 98.9 %
- CAS
- 851983-85-2
Compound Identifiers & Properties
- CAS
- 851983-85-2
- PubChem CID
- 11188409
- SMILES
- C[C@]12CC[C@@H](CC1=CC[C@@H]3[C@@H]2CC[C@]4([C@H]3CC=C4N5C=NC6=CC=CC=C65)C)O
- Canonical SMILES
- C[C@]12CC[C@H](O)CC1=CC[C@@H]1[C@@H]2CC[C@]2(C)C(n3cnc4ccccc43)=CC[C@@H]12
Names & Synonyms
- Galeterone
- Galaterone
- TOK-001
- 851983-85-2
- galeterona
- galeteronum
- Geleterone
- Galeterone [USAN]
- TOK 001
- Galeterone (USAN)
- Galeterone Impurity 1
- Tok-001 (galeterone)
- Galeterone [USAN:INN]
- TOK-001(Galeterone)
- TOK-001; Galeterone
- GALETERONE [INN]
- VN/124-1
- RefChem:142163
- UNII-WA33E149SW
- WA33E149SW
- TOK-OO1
- TOK-001(Galeterone)?
- VN/124
- D0U0BU
- C26H32N2O
- CPD-1
- GALETERONE [WHO-DD]
- cc-264
- SCHEMBL939234
- MFCD16660907
- VN 124
- VN-124
- DTXSID101025602
- GTPL8638
- orb1300706
- CHEMBL2105738
- Galeterone, >=98% (HPLC)
- SCHEMBL29350724
- CHEBI:177536
- PAFKTGFSEFKSQG-PAASFTFBSA-N
- BCPP000040
- DTXCID801509865
- AMY27882
- BCP02827
- EX-A1025
- TOK-001/
- ZINC6718442
- ABP000369
- BDBM50435990
- VN-124-1
- AKOS005146524
- CM11049
- CS-0334
- DB12415
- FT65187
- NX41765
- RL05280
- TOK-001;VN-124-1
- CID11188409
- AC-26549
- AS-56204
- CID 11188409
- CID:11188409
- HY-70006
- SC-96681
- SID:53789573
- 3-hydroxy-17-(1H-benzimidazole-1-yl)androsta-5,16-diene
- A8623
- FT-0774426
- NS00070343
- Y0281
- (3S,8R,9S,10R,13S,14S)-17-(benzimidazol-1-yl)-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-3-ol
- 17-(1H-Benzimidazol-1-yl)androsta-5,16-dien-3beta-ol
- J2.952.671K
- Benzene,1,3,5-tris(3,3-dimethyl-1-butynyl)
- D10125
- W-5660
- A858327
- C500627
- C570636
- Q5518498
- (3beta)-17-(1h-benzimidazol-1-yl)androsta-5,16-dien-3-ol
- 3beta-hydroxy-17-(1H-benzimidazole-1-yl)androsta-5,16-diene
- (3S,8R,9S,10R,13S,14S)-17-(1H-Benzo[d]imidazol-1-yl)-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol
- (3?)-17-(1H-Benzimidazol-1-yl)androsta-5,16-dien-3-ol
- 17-(1H-Benzoimidazole-1-yl)androsta-5,16-diene-3beta-ol
- Androsta-5,16-dien-3-ol, 17-(1H-benzimidazol-1-yl)-, (3beta)-
- B0084-251227
- VN/124-1;TOK-001;VN 124;TOK001;TOK 001
- 17-(1H-Benzoimidazole-1-yl)-androsta-5,16-diene-3beta-ol
- 3beta-Hydroxy-17-(1H-benzimidazol-1-yl)-androsta-5,16-diene
- 3beta-Hydroxy-17-(1H-benzimidazol-1-yl)androsta-5,16-diene
- 3beta-Hydroxy-17-(1H-benzoimidazole-1-yl)androsta-5,16-diene
- Specific Androgen Receptor Modulator/CYP17 Lyase Inhibitor TOK-001
- (3alpha,8alpha)-17-(1h-Benzimidazol-1-Yl)androsta-5,16-Dien-3-Ol
- ANDROSTA-5,16-DIEN-3-OL, 17-(1H-BENZIMIDAZOL-1-YL)-, (3.BETA.)-
- (1S,2R,5S,10R,11S,15S)-14-(1H-1,3-benzodiazol-1-yl)-2,15-dimethyltetracyclo(8.7.0.02,?.011,1?)heptadeca-7,13-dien-5-ol
- (3aS,3bR,7S,9aR,9bS,11aS)-1-(1H-1,3-benzodiazol-1-yl)-9a,11a-dimethyl-3H,3aH,3bH,4H,6H,7H,8H,9H,9aH,9bH,10H,11H,11aH-cyclopenta[a]phenanthren-7-ol
- (3S,8R,9S,10R,13S,14S)-17-(benzimidazol-1-yl)-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta(a)phenanthren-3-ol
- 2061-71-4
- 8-hydroxy-10a,12a-dimethyl-3,4,4a,4b,5,6,6a,7,8,9,10,10b,11,12-tetradecahydronaphtho[2,1-f]chromen-2-one